SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001193125-23-148004 from BIOCEPT INC (BIOCQ) (CIK 0001044378)

BIOCEPT INC (BIOCQ) (CIK 0001044378)
Date: May 18, 2023 · CIK: 0001044378 · Accession: 0001193125-23-148004

AI Filing Summary & Sentiment

File numbers found in text: 333-271355

Date
May 18, 2023
Author
EF HUTTON, DIVISION OF BENCHMARK INVESTMENTS, LLC
Form
CORRESP
Company
BIOCEPT INC (BIOCQ) (CIK 0001044378)

Letter

Re: Biocept, Inc.

May 18, 2023

VIA EDGAR

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Registration Statement on Form S-1 (File No. 333-271355) – Withdrawal of Acceleration Request

Ladies and Gentlemen:

Reference is made to our letter, filed as correspondence via EDGAR on May 16, 2023, in which we, as representative of the underwriters in an offering pursuant to the registration statement on Form S-1 (333-271355) (the “Registration Statement”), joined Biocept, Inc.’s request for acceleration of the effective date of the above-referenced Registration Statement for May 18, 2023, at 9:00 A.M. (New York time). Biocept, Inc. is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.

Very truly yours,
EF HUTTON, DIVISION OF BENCHMARK INVESTMENTS, LLC

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 May 18, 2023

VIA EDGAR

 Securities and Exchange Commission

100 F Street, N.E.

 Washington, DC 20549

Re:
 Biocept, Inc.

Registration Statement on Form S-1 (File
No. 333-271355) – Withdrawal of Acceleration Request

 Ladies and Gentlemen:

Reference is made to our letter, filed as correspondence via EDGAR on May 16, 2023, in which we, as representative of the
underwriters in an offering pursuant to the registration statement on Form S-1 (333-271355) (the “Registration Statement”), joined Biocept, Inc.’s
request for acceleration of the effective date of the above-referenced Registration Statement for May 18, 2023, at 9:00 A.M. (New York time). Biocept, Inc. is no longer requesting that such Registration Statement be declared effective at this
time and we hereby formally withdraw our request for acceleration of the effective date.

 Very truly yours,

EF HUTTON, DIVISION OF BENCHMARK INVESTMENTS, LLC

 By:

 /s/ Sam Fleischman

 Name:

 Sam Fleischman

 Title:

 Supervisory Principal